{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:33:35Z","timestamp":1784918015340,"version":"3.55.0"},"reference-count":43,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["15K09432"],"award-info":[{"award-number":["15K09432"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["19K09003"],"award-info":[{"award-number":["19K09003"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Paradoxical increases in serum cortisol in the dexamethasone suppression test (DST) have been rarely observed in Cushing disease (CD). Its pathophysiology and prevalence remain unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case Description<\/jats:title>\n                  <jats:p>A 62-year-old woman with suspected CD showed paradoxical increases in cortisol after both 1-mg and 8-mg DST (1.95-fold and 2.52-fold, respectively). The initiation of metyrapone paradoxically decreased plasma adrenocorticotropic hormone (ACTH) levels and suppressed cortisol levels. Moreover, the pituitary tumor considerably shrank during metyrapone treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ex Vivo Experiments<\/jats:title>\n                  <jats:p>The resected tumor tissue was enzymatically digested, dispersed, and embedded into Matrigel as 3D cultured cells. ACTH levels in the media were measured. In this tumor culture, ACTH levels increased 1.3-fold after dexamethasone treatment (P &amp;lt; 0.01) while control tumor cultures exhibited no increase in ACTH levels, but rather a 20% to 40% suppression (P &amp;lt; 0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Study<\/jats:title>\n                  <jats:p>A cross-sectional, retrospective, multicenter study that included 92 patients with CD who underwent both low-dose and high-dose DST from 2014 to 2020 was performed. Eight cases (8.7%) showed an increase in serum cortisol after both low-dose and high-dose DST.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This is the first report of a patient with glucocorticoid (GC)-driven positive feedback CD who showed both ACTH suppression and tumor shrinkage by metyrapone. Our cohort study revealed that 8.7% of patients with CD patients possibly possess GC-driven positive-feedback systems, thereby suggesting the presence of a new subtype of CD that is different from the majority of CD cases. The mechanisms exhibiting GC positive feedback in CD and the therapeutic approach for these patients remain to be investigated.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvab055","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T05:36:18Z","timestamp":1617168978000},"source":"Crossref","is-referenced-by-count":15,"title":["Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback"],"prefix":"10.1210","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6028-1022","authenticated-orcid":false,"given":"Yasutaka","family":"Tsujimoto","sequence":"first","affiliation":[{"name":"Division of Diabetes and Endocrinology, Akashi Medical Center Hospital, Akashi 674-0063, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shichi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-653X","authenticated-orcid":false,"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Akashi Medical Center Hospital, Akashi 674-0063, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Inoshita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Metropolitan Geriatric Medical Center, Tokyo 173-0015, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Pituitary Center, Moriyama Memorial Hospital, Tokyo 134-0088, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Yamada","sequence":"additional","affiliation":[{"name":"Pituitary Center, Moriyama Memorial Hospital, Tokyo 134-0088, Japan"},{"name":"Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo 105-8470, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Kobe University School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Chihara","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Akashi Medical Center Hospital, Akashi 674-0063, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"issue":"10","key":"2021121114451262500_CIT0001","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-Tumor Endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N Engl J Med."},{"issue":"5","key":"2021121114451262500_CIT0002","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021121114451262500_CIT0003","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10253890.2018.1470238","article-title":"Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility","volume":"21","author":"Gjerstad","year":"2018","journal-title":"Stress."},{"issue":"2","key":"2021121114451262500_CIT0004","first-page":"181","article-title":"Ectopic ACTH syndrome due to pheochromocytoma: case report and review of the literature","volume":"52","author":"Forman","year":"1979","journal-title":"Yale J Biol Med."},{"issue":"11","key":"2021121114451262500_CIT0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/BF03347794","article-title":"Cyclic Cushing\u2019s syndrome due to ectopic ACTH secretion by an adrenal pheochromocytoma","volume":"17","author":"Terzolo","year":"1994","journal-title":"J Endocrinol Invest."},{"issue":"6","key":"2021121114451262500_CIT0006","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1507\/endocrj.50.739","article-title":"A case of ACTH-producing pheochromocytoma associated with pregnancy","volume":"50","author":"Oh","year":"2003","journal-title":"Endocr J."},{"issue":"9","key":"2021121114451262500_CIT0007","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/BF03350818","article-title":"Ectopic ACTH syndrome caused by pheochromocytoma: computed tomography-guided percutaneous ethanol injection as an alternative treatment","volume":"30","author":"Danilovic","year":"2007","journal-title":"J Endocrinol Invest."},{"issue":"1","key":"2021121114451262500_CIT0008","first-page":"3924","article-title":"Cushing\u2019s syndrome due to ACTH-secreting pheochromocytoma","volume":"15","author":"Brenner","year":"2008","journal-title":"Can J Urol."},{"issue":"3","key":"2021121114451262500_CIT0009","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12022-012-9212-0","article-title":"ACTH-secreting pheochromocytoma with false-negative ACTH immunohistochemistry","volume":"23","author":"Cassarino","year":"2012","journal-title":"Endocr Pathol."},{"issue":"3","key":"2021121114451262500_CIT0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2015-2855","article-title":"Cushing syndrome due to ACTH-secreting pheochromocytoma, aggravated by glucocorticoid-driven positive-feedback loop","volume":"101","author":"Sakuma","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021121114451262500_CIT0011","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12020-016-1127-y","article-title":"Frequency of Cushing\u2019s syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center","volume":"55","author":"Falhammar","year":"2017","journal-title":"Endocrine."},{"issue":"7","key":"2021121114451262500_CIT0012","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1507\/endocrj.EJ18-0025","article-title":"Metyrapone-responsive ectopic ACTH-secreting pheochromocytoma with a vicious cycle via a glucocorticoid-driven positive-feedback mechanism","volume":"65","author":"Inoue","year":"2018","journal-title":"Endocr J."},{"issue":"5","key":"2021121114451262500_CIT0013","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1210\/jc.2018-02268","article-title":"ACTH-dependent cyclic Cushing syndrome triggered by glucocorticoid excess through a positive-feedback mechanism","volume":"104","author":"Seki","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021121114451262500_CIT0014","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1507\/endocrj.EJ12-0299","article-title":"Evaluation of the diagnostic criteria for Cushing\u2019s disease in Japan","volume":"60","author":"Kageyama","year":"2013","journal-title":"Endocr J."},{"issue":"1","key":"2021121114451262500_CIT0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet."},{"issue":"1","key":"2021121114451262500_CIT0016","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1038\/s41467-018-05275-5","article-title":"Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease","volume":"9","author":"Chen","year":"2018","journal-title":"Nat Commun."},{"issue":"4","key":"2021121114451262500_CIT0017","doi-asserted-by":"crossref","first-page":"e0175435","DOI":"10.1371\/journal.pone.0175435","article-title":"Role of NeuroD1 on the negative regulation of Pomc expression by glucocorticoid","volume":"12","author":"Parvin","year":"2017","journal-title":"PLoS One."},{"issue":"4","key":"2021121114451262500_CIT0018","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0002-9343(69)90191-0","article-title":"Cushing\u2019s syndrome with a paradoxical response to dexamethasone","volume":"47","author":"French","year":"1969","journal-title":"Am J Med."},{"issue":"3","key":"2021121114451262500_CIT0019","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1210\/jcem-36-3-445","article-title":"Cushing\u2019s disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone","volume":"36","author":"Ronald","year":"1973","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021121114451262500_CIT0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1210\/jcem-43-4-913","article-title":"Periodic remission in Cushing\u2019s disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis","volume":"43","author":"Liberman","year":"1976","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021121114451262500_CIT0021","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/jcem-64-1-170","article-title":"Cyclical edema and hypokalemia due to occult episodic hypercorticism","volume":"64","author":"Kuchel","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021121114451262500_CIT0022","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF03347559","article-title":"Cyclic Cushing\u2019s disease with paradoxical response to dexamethasone","volume":"28","author":"Checchi","year":"2005","journal-title":"J Endocrinol Invest."},{"issue":"8","key":"2021121114451262500_CIT0023","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021121114451262500_CIT0024","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","article-title":"Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing\u2019s syndrome","volume":"35","author":"Verhelst","year":"1991","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"12","key":"2021121114451262500_CIT0025","first-page":"4771","article-title":"Cushing\u2019s syndrome due to phaeochromocytoma secreting the precursors of adrenocorticotropin","volume":"85","author":"White","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021121114451262500_CIT0026","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1983.tb00580.x","article-title":"Suppressive effect of metyrapone on plasma corticotrophin immunoreactivity in normal man","volume":"18","author":"Sch\u00f6nesh\u00f6fer","year":"1983","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021121114451262500_CIT0027","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/eje.0.1470201","article-title":"Sequential ACTH and catecholamine secretion in a phaeochromocytoma","volume":"147","author":"van Dam","year":"2002","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021121114451262500_CIT0028","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/cren.2016.0122","article-title":"Laparoscopic unilateral total and contralateral subtotal adrenalectomy for bilateral adrenocorticotropic hormone-secreting pheochromocytoma: report of a rare case","volume":"2","author":"Fukasawa","year":"2016","journal-title":"J Endourol Case Rep."},{"issue":"4","key":"2021121114451262500_CIT0029","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1530\/eje.0.1350440","article-title":"Spontaneous remission of ectopic Cushing\u2019s syndrome due to pheochromocytoma: a case report","volume":"135","author":"Loh","year":"1996","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021121114451262500_CIT0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12902-018-0246-2","article-title":"Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review","volume":"18","author":"Iwayama","year":"2018","journal-title":"BMC Endocr Disord."},{"issue":"5","key":"2021121114451262500_CIT0031","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41419-018-0558-1","article-title":"A dual role for glucocorticoid-induced leucine zipper in glucocorticoid function: tumor growth promotion or suppression?","volume":"9","author":"Ayroldi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"10","key":"2021121114451262500_CIT0032","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/1078-0432.CCR-05-2085","article-title":"Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells","volume":"12","author":"Yano","year":"2006","journal-title":"Clin Cancer Res."},{"issue":"6","key":"2021121114451262500_CIT0033","doi-asserted-by":"crossref","first-page":"e0178937","DOI":"10.1371\/journal.pone.0178937","article-title":"Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One."},{"issue":"2","key":"2021121114451262500_CIT0034","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ydbio.2016.06.036","article-title":"Reverse engineering liver buds through self-driven condensation and organization towards medical application","volume":"420","author":"Shinozawa","year":"2016","journal-title":"Dev Biol."},{"issue":"3","key":"2021121114451262500_CIT0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.stem.2017.08.016","article-title":"Synergistic engineering: organoids meet organs-on-a-chip","volume":"21","author":"Takebe","year":"2017","journal-title":"Cell Stem Cell."},{"issue":"6444","key":"2021121114451262500_CIT0036","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science."},{"issue":"6","key":"2021121114451262500_CIT0037","first-page":"2728","article-title":"Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors","volume":"86","author":"Korbonits","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021121114451262500_CIT0038","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nm.3776","article-title":"A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease","volume":"21","author":"Riebold","year":"2015","journal-title":"Nat Med."},{"issue":"20","key":"2021121114451262500_CIT0039","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1101\/gad.1444606","article-title":"Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease","volume":"20","author":"Bilodeau","year":"2006","journal-title":"Genes Dev."},{"issue":"5","key":"2021121114451262500_CIT0040","first-page":"257","article-title":"Steroid-dependent ACTH-produced thymic carcinoid: regulation of POMC gene expression by cortisol via methylation of its promoter region","volume":"67","author":"Mizoguchi","year":"2007","journal-title":"Horm Res."},{"issue":"11","key":"2021121114451262500_CIT0041","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1530\/ERC-16-0206","article-title":"E2F1-mediated human POMC expression in ectopic Cushing\u2019s syndrome","volume":"23","author":"Araki","year":"2016","journal-title":"Endocr Relat Cancer."},{"issue":"2","key":"2021121114451262500_CIT0042","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/js.2016-1053","article-title":"EGFR induces E2F1-mediated corticotroph tumorigenesis","volume":"1","author":"Araki","year":"2017","journal-title":"J Endocr Soc."},{"issue":"3","key":"2021121114451262500_CIT0043","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1530\/EJE-07-0262","article-title":"Cyclic Cushing\u2019s syndrome: a clinical challenge","volume":"157","author":"Meinardi","year":"2007","journal-title":"Eur J Endocrinol."}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvab055\/36830464\/bvab055.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/5\/6\/bvab055\/41726063\/bvab055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/5\/6\/bvab055\/41726063\/bvab055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T14:45:49Z","timestamp":1639233949000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvab055\/6205391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvab055","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,3,30]]},"article-number":"bvab055"}}